What is the ELIXA study? 

ELIXA is a clinical trial being done to see if lowering the blood sugar with an experimental anti-diabetes medication will prevent future heart attacks and strokes in people with type 2 diabetes who have already experienced a cardiovascular event. The experimental medication, called lixisenatide, will be compared to a placebo (a substance that has no therapeutic effect). This study is for people who have diabetes and who have recently been in the hospital for a cardiovascular event such as a heart attack or unstable angina. If you enroll in ELIXA you will receive all study-related medical care and diabetes testing supplies for free and diet and exercise counseling. Most importantly, a study doctor will closely monitor your diabetes and heart disease.